Promoter hypermethylation of tumor-related genes in sporadic colorectal cancer in young patients

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 521-526

  Noda, Hiroshi ^a   Mashima, R ^a   Kamiyama, H ^a   Okada, S ^a   Kawamura, Y J ^a   Konishi, F ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; Sporadic colorectal cancer; Young patient

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, P16; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TUMOR SUPPRESSOR PROTEINS;

EID: 38549103114     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Heys S.D., O'Hanrahan T.J., Brittenden J., Eremin O.: Colorectal cancer in young patients: a review of literature. Eur. J. Surg. Oncol. 20:225-231,1994.
2. Enblad G., Enblad P., Adami H.O., Glimelius B., Krusemo U., Pahlman L : Relationship between age and survival in cancer of the colon and rectum with special reference to patients less than 40 years of age. Br. J.Surg. 77:611-616,1990.
3. Mirty E., Benhamiche A.M., Jouve J.L., Clinard F., FinnFaivre C., Faivre J.: Colorectal adenocarcinoma in patients under 45 years of age: Comparison with older patients in a well-defined French population. Dis. Colon. Rectum. 44:380-387,2001.
4. Liang J.T., Huang K.C., Cheng A.L., Jeng Y.M., Wu M.S., Wang S.M.: Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br. J. Surg. 90:205-214,2003.
5. Behbehani A., Sakwa M., Ehrlichman R., Maquire P., Friedman S., Steele G.D. Jr., Wilson R.E.: Colorectal carcinoma in patients under age 40. Ann. Surg. 202:610-614,1985
6. Chung Y.F., Eu K.W., Machin D., Ho J.M., Nyam D.C., Leong A.F., Ho Y.H., Seow-Choen F.: Young age is not a poor prognosis marker in colorectal cancer. Br. J. Surg. 85:1255-1259,1998.
7. Smith C., Butler J.A.: Colorectal cancer in patients younger than 40 years of age. Dis. Colon. Rectum. 32:843-846,1989.
8. Griffin P.M., Liff J.M., Greenberg R.S., Clark W.S.: Adenocarcinoma of the colon and rectum in persons under 40 years old. Gastroenterology. 100:1033-1040,1991.
9. Chiang J.M., Chen M.C., Changchien C.R., Chen J.S., Tang R., Wang J.Y., Yeh C.Y., Fan C.W., Tsai W.S.: Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma. Patients 30 years of age or younger may be a distinct patient group. Dis. Colon. Rectum. 46:904-910,2003.
10. Hall N.R., Finan P.J., Ward B., Turner G., Bishop D.T.: Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br. J. Surg. 81:1485-1489,1994.
11. Fante R., Benatti P., di Gregorio C., De Pietri S., Pedroni M., Tamassia M.G., Percesepe A., Rossi G., Losi L., Roncucci L., Ponz de. L.M. Colorectal carcinoma in different age groups: a population-based investigation. Am. J. Gastroenterol. 92:1505-1509,1997.
12. Guillem J.G., Bastar A.L., Ng. J., Huhn J.L., Cohen A.M.: Clustering of colorectal cancer in families of probands under 40 years of age. Dis. Colon. Rectum. 39:1004-1007,1996.
13. Guillem J.G., Calle Jr. J.P.L., Cellini C., Murray M., Ng. J., Fazzari M., Paty P.B., Quan S.H.Q., Wong W.D., Cohen A.M.: Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients. Dis. Colon. Rectum. 42:36-42,1999
14. Baylin S.B., Herman J.G.: DNA hypermethylation in tumoriogenesis: epigenetics joins genetics. Trends. Genet. 16:168-174,2000.
15. Jones P.A., Baylin S.B.: The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:415-428,2002.
16. Esteller M.: CpG island hypermethylation and tumor suppressor genes: a blooming present, a brighter future. Oncogene. 21:5427-5440,2002.
17. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., Issa J.P.: CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA .96:8681-8686,1999.
18. Vasen H.F., Mecklin J.P., Meera K.P., Lynch H.T.: The international collaborative group on hereditary non-polyposis colorectal cancer (HNPCC). Dis. Colon. Rectum. 34:424-425:1991.
19. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B.: Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad.Sci. USA. 93:9821-9826,1996.
20. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Shidransky D., Meltzer S.J., Baylin S.B., Herman J.G.: Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer. Research. 60:4366-4371,2000.
21. van Engeland M., Weijenberg M.P., Roemen G.M.J.M., Brink M., de Bruine A.P., Goldbohm R.A., van den Brandt P.A., Baylin S.B., de Goeij A.F.P.M., Herman J.G .: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer. Research. 63:3133-3137,2003.
22. Herman J.G., Umar A., Polyak K., Graff J.R., Ahuja N., Issa J.P., Markowithz S., Willson J.K.V., Hamilton S.R., Kinzler K.W., Kane M.F., Kolodner R.D., Vogelstein B., Kunkel T.A., Baylin S.B.: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA. 95:6870-6875,1998.
23. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., Herman J.G.: Hypermethylation-associated inactivation of p14ARF is independent of p16INK4a methylation and p53 mutational status. Cancer. Research. 60:129-133,2000.
24. Xu X.L., Yu J., Zhang H.Y., Sun M.H., Gu J., Du X., Shi D.R., Wang P., Yang Z.H., Zhu J.D.: Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World. J. Gastroenterol. 10:3441-3454,2004.
25. van Engeland M.. Roemen G.M.J.M., Brink M., Pachen M.M.M., WeijenbergM.P., de Bruine A.P., Arends J.W., van den Brandt P.A., de Goeij A.F.P.M., Herman J.G.: K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene. 21:3792-3795,2002.
26. Miyakura Y., Sugano K., Konishi F., Ichikawa A., Maekawa M., Shitoh K., Igarashi S., Kotake K., Koyama Y., Nagai H.: Extensive methylation of hMLH1 prpmoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology. 121:1300-1309,2001.
27. Hawkins N., Norrie M., Cheong K., Monkany E., Ku S.L., Meagher A., O'connor T., Ward R.: CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 122:1376-1387;2002.
28. Weber T.K., Conroy J., Keitz B., Rodrigues-Bigas M., Petrelli N.J., Stoler D.L., Anderson G.R., Shows T.B., Nowak N.J.: Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet. Cell. Genet. 86:142-147,1999.
29. Esller M., Hamilton S.R., Burger P.C., Baylin S.B., Herman J.G..: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by the promoter hypermethylation is a common event in primary human neoplasia. Cancer. Res. 59:793-797,1999.
30. Esteller M., Risques R.A., Toyota M., Capella G., Moreno Y., Peinado M.A., Baylin S.B., Herman J.G.: Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer. Res. 61:4689-4692,2001.
31. Esteller M., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Watkins D.N., Issa J.P., Shidransky D., Baylin S.B., Herman J.G..: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer. Res. 60:2368-2371,2000.
32. Gonzalgo M.L., Hayashida T., Bender C.M., Pao M.M., Tsai Y.C., Gonzales F.A., Nguyen H.D., Nguyen T.T., Jones P.A.: The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer. Res. 58:1245-1252,1998.
33. Jang H., Mason J.B., Choi S.W.: Genetic and epigenetic interactions between folate and aging in carcinogenesis. J. Nutr. 135:2967S-2971S,2005.
34. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., Iacopetta B.: DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer. 94:593-598,2006.